A WHO-led program to ensure poorer countries get fair access to Covid-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as $10 per course, a draft document seen by Reuters says.
Merck & Co's experimental pill molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being developed.The document, which outlines the goals of the Access to Covid-19 Tools Accelerator until September next year, says that the program wants to deliver about 1 billion Covid-19 tests to poorer nations, and procure drugs to treat up to 120 million patients globally, out of about 200 million new cases it estimates in the next 12 months.
Poorer nations could miss out againThe ACT-A document says that its target is to reach a deal by the end of November to secure the supply of an"oral outpatient drug," which it aims to be available from the first quarter of next year.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Why COVID-19 booster shots weren't tweaked to better match Delta variantMore COVID-19 booster shots may be on the way — but when it’s your turn, you’ll get an extra dose of the original vaccine formulation, not one updated to better match the extra-contagious Delta variant.
Leer más »
Melbourne to ease world’s longest Covid-19 lockdownMelbourne, Australia, which has spent more time under Covid-19 lockdowns than any other city in the world, is set to lift its stay-at-home orders this week, officials say.
Leer más »
Russia hit by largest daily number of new Covid-19 infectionsRussia is reporting its largest daily number of new coronavirus infections, more than 70 percent up on the number a month ago.
Leer más »
U.S. administers 408.3 mln doses of COVID-19 vaccines - CDCThe United States has administered 408,265,959 doses of COVID-19 vaccines as of Sunday morning, the Centers for Disease Control and Prevention said.
Leer más »